Standard BioTools (LAB) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Standard BioTools Revenue Highlights

Latest Revenue (Y)

$174.43M

Latest Revenue (Q)

$44.97M

Main Segment (Y)

Product And Service

Main Geography (Y)

Americas

Standard BioTools Revenue by Period

Standard BioTools Revenue by Year

Date	Revenue	Change
2024-12-31	$174.43M	64.03%
2023-12-31	$106.34M	8.57%
2022-12-31	$97.95M	-24.99%
2021-12-31	$130.58M	-5.47%
2020-12-31	$138.14M	17.83%
2019-12-31	$117.24M	3.79%
2018-12-31	$112.96M	10.82%
2017-12-31	$101.94M	-2.40%
2016-12-31	$104.45M	-8.95%
2015-12-31	$114.71M	-1.50%
2014-12-31	$116.46M	63.60%
2013-12-31	$71.18M	36.02%
2012-12-31	$52.33M	22.09%
2011-12-31	$42.87M	27.73%
2010-12-31	$33.56M	32.06%
2009-12-31	$25.41M	65.58%
2008-12-31	$15.35M	110.96%
2007-12-31	$7.28M	13.71%
2006-12-31	$6.40M	-95.10%
2001-12-31	$130.58M	-

Standard BioTools generated $174.43M in revenue during NA 2024, up 64.03% compared to the previous quarter, and up 148.78% compared to the same period a year ago.

Standard BioTools Revenue by Quarter

Date	Revenue	Change
2024-09-30	$44.97M	20.87%
2024-06-30	$37.20M	-18.30%
2024-03-31	$45.54M	61.56%
2023-12-31	$28.19M	11.12%
2023-09-30	$25.37M	-8.31%
2023-06-30	$27.67M	10.14%
2023-03-31	$25.12M	-7.04%
2022-12-31	$27.02M	5.36%
2022-09-30	$25.65M	36.58%
2022-06-30	$18.78M	-29.15%
2022-03-31	$26.50M	-30.74%
2021-12-31	$38.27M	34.24%
2021-09-30	$28.50M	-8.10%
2021-06-30	$31.02M	-5.42%
2021-03-31	$32.79M	-26.48%
2020-12-31	$44.61M	11.91%
2020-09-30	$39.86M	52.97%
2020-06-30	$26.06M	-5.65%
2020-03-31	$27.62M	-14.87%
2019-12-31	$32.44M	22.43%
2019-09-30	$26.50M	-6.03%
2019-06-30	$28.20M	-6.36%
2019-03-31	$30.11M	-6.85%
2018-12-31	$32.33M	11.61%
2018-09-30	$28.96M	9.59%
2018-06-30	$26.43M	4.67%
2018-03-31	$25.25M	-9.00%
2017-12-31	$27.75M	12.11%
2017-09-30	$24.75M	3.49%
2017-06-30	$23.91M	-6.35%
2017-03-31	$25.53M	1.79%
2016-12-31	$25.08M	13.04%
2016-09-30	$22.19M	-21.22%
2016-06-30	$28.17M	-2.88%
2016-03-31	$29.00M	-5.60%
2015-12-31	$30.72M	7.26%
2015-09-30	$28.64M	0.09%
2015-06-30	$28.62M	7.07%
2015-03-31	$26.73M	-20.19%
2014-12-31	$33.49M	13.01%
2014-09-30	$29.64M	7.35%
2014-06-30	$27.61M	7.32%
2014-03-31	$25.72M	23.19%
2013-12-31	$20.88M	14.18%
2013-09-30	$18.29M	4.62%
2013-06-30	$17.48M	20.26%
2013-03-31	$14.54M	-7.18%
2012-12-31	$15.66M	22.51%
2012-09-30	$12.78M	-1.28%
2012-06-30	$12.95M	18.30%
2012-03-31	$10.95M	-15.78%
2011-12-31	$13.00M	22.65%
2011-09-30	$10.60M	0.19%
2011-06-30	$10.58M	21.61%
2011-03-31	$8.70M	-16.01%
2010-12-31	$10.36M	22.31%
2010-09-30	$8.47M	5.52%
2010-06-30	$8.02M	19.46%
2010-03-31	$6.72M	-11.90%
2009-12-31	$7.62M	-

Standard BioTools generated $44.97M in revenue during Q3 2024, up 20.87% compared to the previous quarter, and up 162.54% compared to the same period a year ago.

Standard BioTools Revenue Breakdown

Standard BioTools Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Collaboration and Other Revenue	$4.73M	-	-	-	-
Product And Service	$169.70M	$105.18M	$96.17M	-	-
Product	$88.57M	$79.20M	$72.45M	$100.38M	$99.94M
Service	$81.13M	$25.98M	$23.71M	$25.92M	$22.58M
Instruments	$28.50M	$37.46M	$25.66M	$42.50M	-
Consumables	$60.06M	$41.74M	$46.79M	$57.88M	-
Product and Service, Other	-	$1.16M	$964.00K	$1.73M	$6.76M
Collaboration Revenue	-	-	$818.00K	$2.56M	-
License	-	-	$964.00K	$147.00K	-
Grant	-	-	-	$1.58M	-

Standard BioTools's latest annual revenue breakdown by segment (product or service), as of Dec 24: Product And Service (39.22%), Product (20.47%), Service (18.75%), Consumables (13.88%), Instruments (6.59%), and Collaboration and Other Revenue (1.09%).

Quarterly Revenue by Product

Product/Service	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Service	$35.67M	$24.44M	$21.03M	$13.59M	$6.57M	$5.82M	$5.91M	$5.86M	$5.81M	$6.14M	$6.99M	$6.02M	$6.63M	$6.29M	$6.12M	$6.13M	$5.14M	$5.19M	$5.40M	$5.63M
Product	$45.38M	$19.59M	$23.59M	$38.82M	$18.71M	$21.66M	$20.92M	$19.31M	$12.22M	$20.00M	$31.08M	$21.94M	$22.63M	$24.73M	$34.35M	$29.21M	$17.41M	$18.98M	$26.69M	$20.67M
Product And Service	$81.05M	$44.03M	$44.62M	$52.41M	$25.28M	$27.49M	$26.82M	-	-	-	-	-	-	-	-	-	-	-	-	-
Instruments	$18.02M	$5.59M	$4.90M	$16.87M	$9.00M	$11.59M	$2.66M	$7.52M	$14.55M	$10.06M	$10.18M	$7.71M	$12.62M	$8.58M	$9.47M	$15.80M	$9.16M	-	-	-
Consumables	$35.65M	$14.01M	$10.41M	$21.95M	$9.71M	$10.08M	$9.56M	$12.48M	$16.53M	$11.88M	$12.45M	$17.02M	$16.59M	$8.83M	$9.51M	$10.88M	$11.51M	-	-	-
Collaboration and Other Revenue	$2.87M	$938.00K	$921.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product and Service, Other	-	-	-	$892.00K	$90.00K	$180.00K	$-621.00K	$396.00K	$268.00K	$54.00K	$461.00K	$914.00K	$300.00K	$1.45M	$1.34M	$513.00K	-	-	-	-
License	-	-	-	-	-	-	-	-	$396.00K	$268.00K	$54.00K	-	$93.00K	-	-	$63.00K	-	-	-	-
Collaboration Revenue	-	-	-	-	-	-	-	-	$356.00K	$88.00K	$139.00K	$90.00K	$1.48M	$2.69M	$3.18M	$3.00M	-	-	-	-
Grant	-	-	-	-	-	-	-	-	-	-	-	$461.00K	$821.00K	$300.00K	$1.34M	$450.00K	-	-	-	-
Grant Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$350.00K	$350.00K	$200.00K

Standard BioTools's latest quarterly revenue breakdown by segment (product or service), as of Dec 24: Product And Service (37.07%), Product (20.76%), Service (16.31%), Consumables (16.30%), Instruments (8.24%), and Collaboration and Other Revenue (1.31%).

Standard BioTools Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Americas	$93.46M	$46.20M	$43.98M	$63.88M	$74.59M
EMEA	$52.32M	$36.20M	$33.14M	$42.72M	$37.78M
Asia Pacific	$28.65M	$23.94M	$20.83M	$23.98M	$25.78M

Standard BioTools's latest annual revenue breakdown by geography, as of Dec 24: Americas (53.58%), EMEA (29.99%), and Asia Pacific (16.43%).

Quarterly Revenue by Country

Country	Dec 24	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19
Americas	$45.05M	$23.75M	$24.66M	$13.22M	$10.87M	$10.45M	$11.66M	$10.50M	$11.12M	$9.43M	$12.93M	$16.22M	$13.01M	$16.12M	$18.52M	$22.15M	$23.65M	$13.94M	$14.84M	$11.81M
Asia Pacific	$15.13M	$5.16M	$8.36M	$6.20M	$6.34M	$5.78M	$5.62M	$5.74M	$6.45M	$3.67M	$4.96M	$7.79M	$5.38M	$5.68M	$5.13M	$8.17M	$7.37M	$5.56M	$4.68M	$9.07M
EMEA	$23.75M	$16.06M	$12.52M	$8.77M	$8.16M	$11.44M	$7.84M	$10.78M	$8.07M	$5.67M	$8.61M	$14.25M	$10.11M	$9.22M	$9.14M	$14.29M	$8.84M	$6.56M	$8.10M	-

Standard BioTools's latest quarterly revenue breakdown by geography, as of Dec 24: Americas (53.68%), EMEA (28.30%), and Asia Pacific (18.03%).

Standard BioTools Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
FONR	FONAR	$102.88B	$2.02M
BNR	Burning Rock Biotech	$537.43M	$125.62M
NOTV	Inotiv	$490.74M	$119.88M
LAB	Standard BioTools	$174.43M	$44.97M
STIM	Neuronetics	$74.89M	$16.45M
BDSX	Biodesix	$71.32M	$18.15M
MDXH	MDxHealth SA	$70.19M	$19.83M
DRIO	DarioHealth	$27.04M	$6.25M
SERA	Sera Prognostics	$77.00K	$24.00K
NDRA	ENDRA Life Sciences	-	-

LAB Revenue FAQ

What is Standard BioTools’s yearly revenue?

Standard BioTools's yearly revenue for 2024 was $174.43M, representing an increase of 64.03% compared to 2023. The company's yearly revenue for 2023 was $106.34M, representing an increase of 8.57% compared to 2022. LAB's yearly revenue for 2022 was $97.95M, representing a decrease of -24.99% compared to 2021.

What is Standard BioTools’s quarterly revenue?

Standard BioTools's quarterly revenue for Q3 2024 was $44.97M, a 20.87% increase from the previous quarter (Q2 2024), and a 77.27% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $37.2M, a -18.30% decrease from the previous quarter (Q1 2024), and a 34.48% increase year-over-year (Q2 2023). LAB's quarterly revenue for Q1 2024 was $45.54M, a 61.56% increase from the previous quarter (Q4 2023), and a 81.30% increase year-over-year (Q1 2023).

What is Standard BioTools’s revenue growth rate?

Standard BioTools's revenue growth rate for the last 3 years (2022-2024) was 78.09%, and for the last 5 years (2020-2024) was 26.27%.

What are Standard BioTools’s revenue streams?

Standard BioTools's revenue streams in c 24 are Collaboration and Other Revenue, Product And Service, Product, Service, Instruments, and Consumables. Collaboration and Other Revenue generated $4.73M in revenue, accounting 1.09% of the company's total revenue Product And Service generated $169.7M in revenue, accounting 39.22% of the company's total revenue, up 61.35% year-over-year. Product generated $88.57M in revenue, accounting 20.47% of the company's total revenue, up 11.83% year-over-year. Service generated $81.13M in revenue, accounting 18.75% of the company's total revenue, up 212.29% year-over-year. Instruments generated $28.5M in revenue, accounting 6.59% of the company's total revenue, down -23.91% year-over-year. Consumables generated $60.06M in revenue, accounting 13.88% of the company's total revenue, up 43.90% year-over-year.

What is Standard BioTools’s main source of revenue?

For the fiscal year ending Dec 24, the largest source of revenue of Standard BioTools was Product And Service. This segment made a revenue of $169.7M, representing 39.22% of the company's total revenue.